Current Problems in Surgery
Volume 47, Issue 3 , Pages 185-250 , March 2010

Care of the Pediatric Cardiac Surgery Patient—Part 1

  • Avihu Z. Gazit, MD

      Affiliations

    • Assistant Professor of Pediatric Critical Care Medicine and Cardiology, St. Louis Children's Hospital, Washington University School of Medicine, St. Louis, Missouri
    • ,
  • Charles B. Huddleston, MD

      Affiliations

    • Professor of Surgery, Director of Pediatric Cardiothoracic Surgery, St. Louis Children's Hospital, Washington University School of Medicine, St. Louis, Missouri
    • ,
  • Paul A. Checchia, MD

      Affiliations

    • Associate Professor of Pediatric Critical Care Medicine and Cardiology, St. Louis Children's Hospital, Washington University School of Medicine, St. Louis, Missouri
    • ,
  • James Fehr, MD

      Affiliations

    • Associate Professor of Anesthesiology and Pediatrics, St. Louis Children's Hospital, Washington University School of Medicine, St. Louis, Missouri
    • ,
  • A. Thomas Pezzella, MD

      Affiliations

    • Retired Associate Professor of Cardiothoracic Surgery, University of Massachusetts Medical School, Worcester, Massachusetts

References 

  1. Calvin JE, Habet K, Parillo JE. Critical care in the United States (Who are we and how did we get here?). Crit Care Clin. 1997;1E3:363–376
  2. Todres ID. History of pediatric critical care. In:  Fuhrman BP,  Zimmerman JJ editor. Pediatric Critical Care. Philadelphia, PA: Mosby, Elsevier; 2006;p. 7–14
  3. Parker MM, Brilli RJ, Culver K. Multidisciplinary critical care and the role of the subspecialist in the pediatric intensive care unit. In:  Fuhrman BP,  Zimmerman JJ editor. Pediatric Critical Care. Philadelphia, PA: Mosby, Elsevier; 2006;p. 3–6
  4. Friedman WF, Silverman N. Congenital heart disease in infancy and childhood. In:  Braunwald E,  Zipes DP,  Libby P editor. Heart Disease. Philadelphia, PA: WB Saunders; 2001;p. 1505–1591
  5. Hoffman JIE. Incidence, prevalence, and inheritance of congenital heart disease. In:  Moller JH,  Hoffman JI editor. Pediatric Cardiovascular Medicine. New York, NY: Churchill Livingstone; 2000;p. 257–262
  6. Schultz AH, Localio AR, Clark BJ, Ravishankar C, Videon N, Kimmel SE. Epidemiological features of the presentation of critical congenital heart disease: implications for screening. Pediatrics. 2008;121:751–757
  7. Martin JA, Kung HC, Mathews TJ, Hoyert DL, Strobino DM, Guyer B. Annual summary of vital statistics. Pediatrics. 2008;121:788–801
  8. Boneva RS, Botto LD, Moore CA, Yang Q, Correa A, Erickson JD. Mortality associated with congenital heart defects in the United States: trends and racial disparities, 1979-97. Circulation. 2001;103:2376–2381
  9. Tchervenko CI. Hearts for life across the world. In: Presidential Address First Meeting World Society for Pediatric and Congenital Heart Surgery, Washington, DC, May 4, 2007.
  10. Campbell M. Incidence of cardiac malformations at birth and later, and neonatal mortality. Br Heart J. 1973;35:189–200
  11. Campbell M. Natural history of persistent ductus arteriosus. Br Heart J. 1968;30:4–13
  12. Hoffman JIE, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39:1890–1900
  13. Hoffman JIE, Kaplan S, Liberthson RR. Prevalence of congenital heart disease. Am Heart J. 2004;147:425–439
  14. Bull C British Paediatric Cardiac Association. Current and potential impact of fetal diagnosis on prevalence and spectrum of serious congenital heart disease at term in the UK. Lancet. 1999;354:1242–1247
  15. Tworetzky W, McElhinney DB, Reddy VM, Brook MM, Hanley FL, Silverman NH. Improved surgical outcome after fetal diagnosis of hypoplastic left heart syndrome. Circulation. 2001;103:1269–1273
  16. Nora JJ. Multifactorial inheritance hypothesis for the etiology of congenital heart disease (The genetic-environmental interaction). Circulation. 1968;38:604–617
  17. Boudjemline Y, Fermont L, Le Bidois J, Lyonnet S, Sidi D, Bonnet D. Prevalence of 22q11 deletion in fetuses with conotruncal cardiac defects: a 6-year prospective study. J Pediatr. 2001;138:520–524
  18. Heymann MA, Rudolph AM. Effects of congenital heart disease on fetal and neonatal circulations. Prog Cardiovasc Dis. 1972;15:115–143
  19. Auman HJ, Coleman H, Riley HE, Olale F, Tsai HJ, Yelon D. Functional modulation of cardiac form through regionally confined cell shape changes. PLoS Biol. 2007;5:604–615
  20. Yashiro K, Shiratori H, Hamada H. Haemodynamics determined by a genetic programme govern asymmetric development of the aortic arch. Nature. 2007;450:285–288
  21. Boudjemline Y, Fermont L, Le Bidois J, Villain E, Sidi D, Bonnet D. Can we predict 22q11 status of fetuses with tetralogy of Fallot?. Prenat Diagn. 2002;22:231–234
  22. Kamath BM, Spinner NB, Emerick KM, Chudley AE, Booth C, Piccoli DA, et al. Vascular anomalies in Alagille syndrome: a significant cause of morbidity and mortality. Circulation. 2004;109:1354–1358
  23. Buckingham M, Meilhac S, Zaffran S. Building the mammalian heart from two sources of myocardial cells. Nat Rev Genet. 2005;6:826–835
  24. Bruneau BG. The developmental genetics of congenital heart disease. [review] Nature. 2008;451:943–948
  25. Olson EN. Gene regulatory networks in the evolution and development of the heart. Science. 2006;13:1922–1927
  26. Srivastava D. Making or breaking the heart: from lineage determination to morphogenesis [review]. Cell. 2006;126:1037–1048
  27. Formigari R, Michielon G, Digilio MC, Piacentini G, Carotti A, Giardini A, et al. Genetic syndromes and congenital heart defects: how is surgical management affected. Eur J Cardio Thorac Surg. 2009;35:606–614
  28. Bernstein D. Cardiac development. In:  Behrman RE,  Kliegman RE,  Jenson HB editor. Nelson Textbook of Pediatrics. Philadelphia, PA: WB Saunders; 2004;p. 1475–1478
  29. Wessels A, Sedmera D. Developmental anatomy of the heart: a tale of mice and men. Physiol Genomics. 2003;15:165–176
  30. Emmanouilides GC. The development of pediatric cardiology. In:  Emmanouilides GC,  Reimenschneider TA,  Allen HD, et al. editor. Moss and Adams Heart Disease in Infants, Children, and Adolescents. Baltimore, MD: Williams and Wilkins; 1995;XXI-IV
  31. VanPraagh R. Nomenclature and classification: morphologic and segmental approach to diagnosis. In:  Moller JH,  Hoffman JIE editor. Pediatric Cardiovascular Medicine. New York, NY: Churchill Livingstone; 2000;p. 275–288
  32. Anderson RH, Cook AC. The anatomy of congenital cardiac malformations. In:  Yuh DD,  Vricella LA,  Baumgartner WA editor. Johns Hopkins Manual of Cardiothoracic Surgery. New York, NY: McGraw-Hill Medical; 2007;p. 1001–1018
  33. Anderson RH. Nomenclature and classification: sequential segmental analysis. In:  Moller JH,  Hoffman JI editor. Pediatric Cardiovascular Medicine. New York, NY: Churchill Livingstone; 2000;p. 263–274
  34. Weinberg PM. Anatomy and classification of congenital heart disease. In:  Kaiser LR,  Kron IL,  Spray TL editor. Mastery of Cardiothoracic Surgery. Philadelphia, PA: Lippincott Williams & Wilkins; 2007;p. 639–650
  35. Kouchoukos NT, Blackstone EH, Doty DB, Hanley FL, Karp RB. Anatomy, dimensions, and terminology. In: Kirklin/Barratt-Boyes Cardiac Surgery. Philadelphia, PA: Churchill Livingstone; 2003;p. 3–65
  36. Nakata S, Imai Y, Takanashi Y, Kurosawa H, Tezuka K, Nakazawa M. A new method for the quantitative standardization of cross-sectional areas of the pulmonary arteries in congenital heart diseases with decreased pulmonary blood flow. J Thorac Cardiovasc Surg. 1984;88:610–619
  37. Chen BB, Chen SJ, Wu MH, Li YW, Lue HC. EBCT-McGoon ratio (A reliable and useful method to predict pulmonary blood flow non-invasively). Chin J Radiol. 2007;31:1–8
  38. Mavroudis C, Bove EL, Cameron DE, Drinkwater DC, Edwards FH, Hammon JW, et al. The Society of Thoracic Surgeons' national congenital heart surgery database. Ann Thorac Surg. 1995;59:554–556
  39. eds. Mavroudis C, Jacobs JP. International congenital heart surgery nomenclature and database project. Ann Thorac Surg. 2000;69(Suppl 1):1–372
  40. Jacobs JP. Nomenclature and classification for congenital cardiac surgery. In:  Mavroudis C,  Backer CL editor. Pediatric Cardiac Surgery. 3rd ed.. Philadelphia, PA: Mosby; 2003;p. 25–38
  41. Klein MD, Reynolds EM. Developmental physiology of the premature and term newborn. In:  Ziegler MM,  Azizkhan RG,  Weber TR editor. Operative Pediatric Surgery. New York, NY: McGraw-Hill Professional; 2003;p. 37–53
  42. Rudolph A. The fetal circulation ands its adjustments after birth. In:  Moller JH,  Hoffman JIE editor. Pediatric Cardiovascular Medicine. New York, NY: Churchill Livingstone; 2000;p. 60–64
  43. Castaneda AR, Jonas RA, Mayer JE, Hanley FL. Cardiac Surgery of the Neonate and Infant. Philadelphia, PA: WB Saunders; 1994;
  44. Suga H. Cardiac function. In:  Moller JH,  Hoffman JIE editor. Pediatric Cardiovascular Medicine. New York, NY: Churchill Livingstone; 2000;p. 65–77
  45. Chowdhury D. Pathophysiology of congenital heart diseases. [review] Ann Card Anaesth. 2007;10:19–26
  46. Cassorla L. Preoperative evaluation and preparation: a physiological approach. In:  Andropoulis DB,  Stayer SA,  Russell IA editor. Anesthesia for Congenital Heart Disease. Malden, MA: Blackwell, Futura; 2005;p. 175–196
  47. Odegard KC, Laussen PC. Approach to the premature and full term infant. In:  Andropoulis DB,  Stayer SA,  Russell IA editor. Anesthesia for Congenital Heart Disease. Malden, MA: Blackwell, Futura; 2005;p. 197–209
  48. Baum VC, Stayer SA, Andropoulos DB, Russell IA. Approach to the teenaged and adult patient. In:  Andropoulis DB,  Stayer SA,  Russell IA editor. Anesthesia for Congenital Heart Disease. Malden, MA: Blackwell, Futura; 2005;p. 210–222
  49. Chang RR, Klitzner TS. Resources, use, and regionalization of pediatric cardiac services. Curr Opin Cardiol. 2003;18:98–101
  50. American Academy of Pediatricians. Section on cardiology and cardiac surgery (Guidelines for pediatric cardiovascular centers). Pediatrics. 2002;109:544–549
  51. Jacobs ML, Mavroudis C, Jacobs JP, Tchervenkov CI, Pelletier GJ. Report of the 2005 STS congenital heart surgery practice and manpower survey. Ann Thorac Surg. 2006;82:1152–1159
  52. Laussen PC. Pediatric cardiac intensive care. In:  Jonas RA editors. Comprehensive Surgical Management of Congenital Heart Disease. London, United Kingdom: Arnold; 2004;p. 65–115
  53. Shumacker HB. The Evolution of Cardiac Surgery. Bloomington, IN: Indiana University Press; 1992;
  54. Westaby W. Landmarks in Cardiac Surgery. Oxford, United Kingdom: Isis Medical Media; 1997;
  55. Hurt R. The History of Cardiothoracic Surgery from Early Times. New York, NY: Parthenon Publishing; 1996;
  56. Vricella LA, Gott VL, Cameron DE. Milestones in congenital cardiac surgery. In:  Yuh DD,  Vricella LA,  Baumgartner WA editor. Johns Hopkins Manual of Cardiothoracic Surgery. New York, NY: McGraw-Hill Medical; 2007;p. 989–1000
  57. Williams JA, Bansal AK, Kim BJ, Nwakanma LU, Patel ND, Seth AK, et al. Two thousand Blalock-Taussig shunts: a six-decade experience. Ann Thorac Surg. 2007;84:2070–2075discussion 2070-5
  58. Rao PS. Interventional pediatric cardiology: state of the art and future directions. Pediatr Cardiol. 1998;19:107–124
  59. Barach P, Johnson JK, Ahmad A, Galvan C, Bognar A, Duncan R, et al. A prospective observational study of human factors, adverse events, and patient outcomes in surgery for pediatric cardiac disease. J Thorac Cardiovasc Surg. 2008;136:1422–1428
  60. Welke KF, Shen I, Ungerleider RM. Current assessment of mortality rates in congenital cardiac surgery. Ann Thorac Surg. 2006;82:164–170discussion 170-1
  61. Welke KF, Diggs BS, Karamlou T, Ungerleider RM. Comparison of pediatric cardiac surgical mortality rates from national administrative data to contemporary clinical standards. Ann Thorac Surg. 2009;87:216–222discussion 222-3
  62. O'Brien SM, Jacobs JP, Clarke DR, Maruszewski B, Jacobs ML, Walters HL, et al. Accuracy of the Aristotle basic complexity score for classifying the mortality and morbidity potential of congenital heart surgery operations. Ann Thorac Surg. 2007;84:2027–2037discussion 2027-37
  63. Jenkins KJ, Gauvreau K, Newburger JW, Spray TL, Moller JH, Iezzoni LI. Consensus-based method for risk adjustment for surgery for congenital heart disease [review]. J Thorac Cardiovasc Surg. 2002;123:110–118
  64. Jacobs JP, Mavroudis C, Jacobs ML, Maruszewski B, Tchervenkov CI, Lacour-Gayet FG, et al. What is operative mortality: defining death in a surgical registry database: a report of the STS congenital database taskforce and the joint EACTS-STS congenital database committee. Ann Thorac Surg. 2006;81:1937–1941
  65. Miyamoto T, Sinzobahamvya N, Photiadis J, Brecher AM, Asfour B. Survival after surgery with cardiopulmonary bypass in low weight patients. Asian Cardiovasc Thorac Ann. 2008;16:115–119
  66. Ades A, Johnson BA, Berger S. Management of low birth weight infants with congenital heart disease. [review] Clin Perinatol. 2005;32:999–1015x-xi
  67. Abrishamchian R, Kanhai D, Zwets E, Nie L, Cardarelli M. Low birth weight or diagnosis, which is a higher risk? (A meta-analysis of observational studies). Eur J Cardio Thorac Surg. 2006;30:700–705
  68. Oppido G, Napoleone CP, Formigari R, Gabbieri D, Pacini D, Frascaroli G, et al. Outcome of cardiac surgery in low birth weight and premature infants. Eur J Cardio Thorac Surg. 2004;26:44–53
  69. Burke RP, Hannan RL. Reducing the trauma of congenital heart surgery. Surg Clin North Am. 2000;80:1593–1605
  70. In:  Kohn LT,  Corrigan JM,  Donaldson MS editor. To Err is Human: Building a Safer Health System. Washington, DC: National Academy Press; 2000;
  71. Wong DR, Ali IS, Torchiana DF, Agnihotri AK, Bohmer RJ, Vander Salm TJ. Learning in a new cardiac surgery center: an analysis of precursor events. Surgery. 2009;145:131–137
  72. Fabri PJ, Zayas-Castro JL. Human error, not communication and systems, underlies surgical complications. Surgery. 2008;144:557–563discussion 563-5
  73. ElBardissi AW, Weigmann DA, Dearani JA, Daly RC, Sundt TM. Application of the human factors analysis and classification system methodology to the cardiovascular surgery operating room. Ann Thorac Surg. 2007;83:1412–1418discussion 1418-9
  74. de Leval MR. Beyond flatland. J Thorac Cardiovasc Surg. 2003;125:12–19
  75. Stark JF, Stark J. Performance measurement in congenital heart surgery: benefits and drawbacks. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2003;6:171–183
  76. Carthey J, de Leval MR, Reason JT. The human factor in cardiac surgery: errors and near misses in a high technology medical domain. Ann Thorac Surg. 2001;72:300–305
  77. Reason J. Human Error. New York, NY: Cambridge University Press; 1990;
  78. de Leval MR, Carthey J, Wright DJ, Farewell VT, Reason JT. Human factors and cardiac surgery: a multicenter study. J Thorac Cardiovasc Surg. 2000;119(4 Pt. 1):661–672
  79. Edmunds LH, Clark RE, Cohn LH, Grunkemeier GL, Miller DC, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ann Thorac Surg. 1996;62:932–935
  80. Brousseau T, Sharieff GQ. Newborn emergencies: the first 30 days of life. [review] Pediatr Clin North Am. 2006;53:69–84vi
  81. Jaquiss RDB, Tweddell JS. The neonate with congenital heart disease: what the cardiac surgeon needs to know from the neonatologist and the cardiologist. Clin Perinatol. 2005;32:947–961ix
  82. Chin C. The cardiovascular history and physical examination. In:  Reitz BA editors. Congenital Cardiac Surgery. New York, NY: McGraw-Hill Inc; 2002;p. 3–7DD Y
  83. Ogden CL, Kuczmarski RJ, Flegal KM, Mei Z, Guo S, Wei R, et al. Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics. 2002;109:45–60
  84. Myrelid A, Gustafsson J, Ollars B, Annerén G. Growth charts for down's syndrome from birth to 18 years of age. Arch Dis Child. 2002;87:97–103
  85. Khariwala SS, Lee WT, Koltai PJ. Laryngotracheal consequences of pediatric cardiac surgery. Arch Otolaryngol Head Neck Surg. 2005;131:336–339
  86. Tempe DK, Virmani S. Coagulation abnormalities in patients with cyanotic congenital heart disease. J Cardiothorac Vasc Anesth. 2002;16:752–765
  87. Momma K. Approach to the cyanotic neonate. In:  Moller JH,  Hoffman JIE editor. Pediatric Cardiovascular Medicine. New York, NY: Churchill Livingstone; 2000;p. 249–254
  88. Lema G, Vogel A, Canessa R, Jalil R, Carvajal C, Becker P, et al. Renal function and cardiopulmonary bypass in pediatric cardiac surgical patients. Pediatr Nephrol. 2006;21:1446–1451
  89. Kang N, de Leval MR, Elliott M, Tsang V, Kocyildirim E, Sehic I, et al. Extending the boundaries of the primary arterial switch operation in patients with transposition of the great arteries and intact ventricular septum. Circulation. 2004;110(11 suppl 1):II123–II127
  90. Hlavacek AM, Crawford FA, Chessa KS, Shirali GS. Real time three-dimensional echocardiography in congenital heart disease: a continuum of unfulfilled promises?. No. A presently clinically applicable technology with an important future? Yes. Pediatr Cardiol. 2002;23:266–285
  91. Cheng TO, Xie MX, Wang XF, Wang Y, Lu Q. Real-time 3-dimensional echocardiography in assessing atrial and ventricular septal defects: an echocardiographic-surgical correlative study. Am Heart J. 2004;148:1091–1095
  92. Sadagopan SN, Veldtman GR, Sivaprakasam MC, Keeton BR, Gnanapragasam JP, Salmon AP, et al. Correlations with operative anatomy of real time three-dimensional echocardiographic imaging of congenital aortic valvar stenosis. Cardiol Young. 2006;16:490–494
  93. Anwar AM, Soliman O, van den Bosch AE, McGhie JS, Geleijnse ML, ten Cate FJ, et al. Assessment of pulmonary valve and right ventricular outflow tract with real-time three-dimensional echocardiography. Int J Cardiovasc Imaging. 2007;23:167–175
  94. van den Bosch AE, Robbers-Visser D, Krenning BJ, Voormolen MM, McGhie JS, Helbing WA, et al. Comparison of real-time three-dimensional echocardiography to magnetic resonance imaging for assessment of left ventricular mass. Am J Cardiol. 2006;97:113–117
  95. van den Bosch AE, Robbers-Visser D, Krenning BJ, McGhie JS, Helbing WA, Meijboom FJ, et al. Real-time transthoracic three-dimensional echocardiographic assessment of left ventricular volume and ejection fraction in congenital heart disease. J Am Soc Echocardiogr. 2006;19:1–6
  96. Vassalos A, Lilley S, Young D, Peng E, MacArthur K, Pollock J, et al. Tissue Doppler imaging following paediatric cardiac surgery: early patterns of change and relationship to outcome. Interact Cardiovasc Thorac Surg. 2009;9:173–177
  97. Jone PN, Schowengerdt KO. Prenatal diagnosis of congenital heart disease. Pediatr Clin North Am. 2009;56:709–715
  98. Kovalchin JP, Silverman NH. The impact of fetal echocardiography. Pediatr Cardiol. 2004;25:299–306
  99. Yoo SJ, Lee YH, Cho KS, Kim DY. Sequential segmental approach to fetal congenital heart disease. [review] Cardiol Young. 1999;9:430–444
  100. Allan LD. Cardiac anatomy screening: what is the best time for screening in pregnancy?. Curr Opin Obset Gyneol. 2003;15:143–146
  101. Becker R, Wegner RD. Detailed screening for fetal anomalies and cardiac defects at the 11-13-week scan. Ultrasound Obstet Gynecol. 2006;27:613–618
  102. Westin M, Saltvedt S, Bergman G, Kublickas M, Almström H, Grunewald C, et al. Routine ultrasound examination at 12 or 18 gestational weeks for prenatal detection of major congenital heart malformations? (A randomised controlled trial comprising 36,299 fetuses). BJOG. 2006;113:675–682
  103. Lurie IW, Ferencz C, Brenner IJ. Heart disease in infancy: a window to the world of fetal cardiology. Prog Pediatr Cardiol. 1996;5:73–78
  104. Bonnet D, Coltri A, Butera G, Fermont L, Le Bidois J, Kachaner J, et al. Detection of transposition of the great arteries in fetuses reduces neonatal morbidity and mortality. Circulation. 1999;99:916–918
  105. Mahle WT, Clancy RR, McGaurn SP, Goin JE, Clark BJ. Impact of prenatal diagnosis on survival and early neurologic morbidity in neonates with the hypoplastic left heart syndrome. Pediatrics. 2001;107:1277–1282
  106. Buchel ERV, DiBernardo S, Bauersfeld U, Berger F. Contrast-enhanced magnetic resonance angiography of the great arteries in patients with congenital heart disease: an accurate tool for planning catheter-guided interventions. Int J Cardiovasc Imaging. 2005;21:313–322
  107. Muthurangu V, Taylor AM, Hegde SR, Johnson R, Tulloh R, Simpson JM, et al. Cardiac magnetic resonance imaging after stage I Norwood operation for hypoplastic left heart syndrome. Circulation. 2005;112:3256–3263
  108. Sorensen TS, Körperich H, Greil GF, Eichhorn J, Barth P, Meyer H, et al. Operator-independent isotropic three-dimensional magnetic resonance imaging for morphology in congenital heart disease: a validation study. Circulation. 2004;110:163–169
  109. Prasad SK, Soukias N, Hornung T, Khan M, Pennell DJ, Gatzoulis MA, et al. Role of magnetic resonance angiography in the diagnosis of major aortopulmonary collateral arteries and partial anomalous pulmonary venous drainage. Circulation. 2004;109:207–214
  110. Geva T, Greil GF, Marshall AC, Landzberg M, Powell AJ. Gadolinium-enhanced 3-dimensional magnetic resonance angiography of pulmonary blood supply in patients with complex pulmonary stenosis or atresia: comparison with X-ray angiography. Circulation. 2002;106:473–478
  111. Fratz S, Hess J, Schwaiger M, Martinoff S, Stern HC. More accurate quantification of pulmonary blood flow by magnetic resonance imaging than by lung perfusion scintigraphy in patients with fontan circulation. Circulation. 2002;106:1510–1513
  112. Hong YK, Park YW, Ryu SJ, Won JW, Choi JY, Sul JH, et al. Efficacy of MRI in complicated congenital heart disease with visceral heterotaxy syndrome. J Comput Assist Tomogr. 2000;24:671–682
  113. Greil GF, Powell AJ, Gildein HP, Geva T. Gadolinium-enhanced three-dimensional magnetic resonance angiography of pulmonary and systemic venous anomalies. J Am Coll Cardiol. 2002;39:335–341
  114. Beekman RP, Hoorntje TM, Beek FJ, Kuijten RH. Sedation for children undergoing magnetic resonance imaging: efficacy and safety of rectal thiopental. Eur J Pediatr. 1996;155:820–822
  115. Malviya S, Voepel-Lewis T, Eldevik OP, Rockwell DT, Wong JH, Tait AR. Sedation and general anaesthesia in children undergoing MRI and CT: adverse events and outcomes. Br J Anaesth. 2000;84:743–748
  116. Malviya S, Voepel-Lewis T, Prochaska G, Tait AR. Prolonged recovery and delayed side effects of sedation for diagnostic imaging studies in children. Pediatrics. 2000;105:E42
  117. Mason KP, Zurakowski D, Connor L, Karian VE, Fontaine PJ, Sanborn PA, et al. Infant sedation for MR imaging and CT: oral versus intravenous pentobarbital. Radiology. 2004;233:723–728
  118. Merola C, Albarracin C, Lebowitz P, Bienkowski RS, Barst SM. An audit of adverse events in children sedated with chloral hydrate or propofol during imaging studies. Paediatr Anaesth. 1995;5:375–378
  119. Dorfman AL, Odegard KC, Powell AJ, Laussen PC, Geva T. Risk factors for adverse events during cardiovascular magnetic resonance in congenital heart disease. J Cardiovasc Magn Reson. 2007;9:793–798
  120. Oosterhof T, van Straten A, Vliegen HW, Meijboom FJ, van Dijk AP, Spijkerboer AM. Preoperative thresholds for pulmonary valve replacement in patients with corrected tetralogy of Fallot using cardiovascular magnetic resonance. Circulation. 2007;116:545–551
  121. Therrien J, Provost Y, Merchant N, Williams W, Colman J, Webb G. Optimal timing for pulmonary valve replacement in adults after tetralogy of Fallot repair. Am J Cardiol. 2005;95:779–782
  122. Buechel ERV, Dave HH, Kellenberger CJ, Dodge-Khatami A, Pretre R, Berger F, et al. Remodeling of the right ventricle after early pulmonary valve replacement in children with repaired tetralogy of Fallot: assessment by cardiovascular magnetic resonance. Eur Heart J. 2005;26:2721–2727
  123. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct size, and contractile function. Circulation. 1999;100:1992–2002
  124. Babu-Narayan SV, Kilner PJ, Li W, Moon JC, Goktekin O, Davlouros PA, et al. Ventricular fibrosis suggested by cardiovascular magnetic resonance in adults with repaired tetralogy of Fallot and its relationship to adverse markers of clinical outcome. Circulation. 2006;113:405–413
  125. Babu-Narayan SV, Goktekin O, Moon JC, Broberg CS, Pantely GA, Pennell DJ, et al. Late gadolinium enhancement cardiovascular magnetic resonance of the systemic right ventricle in adults with previous atrial redirection surgery for transposition of the great arteries. Circulation. 2005;11:2091–2098
  126. Giardini A, Lovato L, Danti A, Formigari R, Oppido G, Gargiulo G, et al. Relation between right ventricular structural alterations and markers of adverse clinical outcome in adults with systemic right ventricle and either congenital complete (after Senning operation), or congenitally corrected transposition of the great arteries. Am J Cardiol. 2006;98:1277–1282
  127. Kondo C, Takada K, Yokoyama U, Nakajima Y, Momma K, Sakai F. Comparison of three-dimensional contrast-enhanced magnetic resonance angiography and axial radiographic angiography for diagnosing congenital stenoses in small pulmonary arteries. Am J Cardiol. 2001;87:420–424
  128. Silverman JM, Julien PJ, Herfkens RJ, Pelc NJ. Quantitative differential pulmonary perfusion: MR imaging versus radionuclide lung scanning. Radiology. 1993;189:699–701
  129. Fratz S, Hess J, Schwaiger M, Martinoff S, Stern HC. More accurate quantification of pulmonary blood flow by magnetic resonance imaging than by lung perfusion scintigraphy in patients with fontan circulation. Circulation. 2002;106:1510–1513
  130. Sridharan S, Derrick G, Deanfield J, Taylor AM. Assessment of differential branch pulmonary blood flow: a comparative study of phase contrast magnetic resonance imaging and radionuclide lung perfusion imaging. Heart. 2006;92:963–968
  131. Nielsen JC, Powell AJ, Gauvreau K, Marcus EN, Prakash A, Geva T. Magnetic resonance imaging predictors of coarctation severity. Circulation. 2005;234:542–547
  132. Crean A. Cardiovascular MR and CT in congenital heart disease. Heart. 2007;93:1634–1647
  133. Taylor AM, Dymarkowski S, Hamaekers P, Razavi R, Gewillig M, Mertens L, et al. MR coronary angiography and late-enhancement myocardial MR in children who underwent arterial switch surgery for transposition of great arteries. Radiology. 2005;234:542–547
  134. Chen SJ, Lin MT, Lee WJ, Liu KL, Wang JK, Chang CI, et al. Coronary artery anatomy in children with congenital heart disease by computed tomography. Int J Cardiol. 2007;120:363–370
  135. Pfammatter JP, Berdat PA, Carrel TP, Stocker FP. Pediatric open heart operations without diagnostic cardiac catheterization. Ann Thorac Surg. 1999;68:532–536
  136. Chowdhury UK, Airan B, Kothari SS, Sharma R, Subramaniam GK, Bhan A, et al. Surgical outcome of staged univentricular-type repairs for patients with univentricular physiology and pulmonary hypertension. Indian Heart J. 2004;56:320–327
  137. Penny DJ, Shekerdemian LS. Management of the neonate with symptomatic congenital heart disease. Arch Dis Child Fetal Neonatal Ed. 2001;84:F141–F145
  138. Finan E, Mak W, Bismilla Z, McNamara PJ. Early discontinuation of intravenous prostaglandin E1 after balloon atrial septostomy is associated with an increased risk of rebound hypoxemia. J Perinatol. 2008;28:341–346
  139. Rocchini AP. Interventional cardiology. In:  Mavroudis C editors. Pediatric Cardiac Surgery. 3rd ed.. Philadelphia, PA: Mosby; 2003;p. 74–99
  140. Hickey PR, Hansen DD, Wessel DL, Lang P, Jonas RA. Blunting of stress responses in the pulmonary circulation of infants by fentanyl. Anesth Analg. 1985;64:1137–1142
  141. Fackler JC, Arnold JH. Anesthetic principles and operating room anesthesia regimens. In:  Fuhrman BP,  Zimmerman J editor. Pediatric Critical Care. Philadelphia, PA: Mosby, Elsevier; 2006;p. 1719–1747
  142. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation. 1996;93:841–842
  143. Chang A, Hanley F, Wernovsky G, Wessel DL. Pediatric Cardiac Intensive Care. In: Baltimore, MD: Lippincott Williams & Wilkins; 1998;p. 492
  144. Burrows FA, Klinck JR, Rabinovitch M, Bohn DJ. Pulmonary hypertension in children: perioperative management. Can Anaesth Soc J. 1986;33:606–628
  145. Gassner S, Cohen M, Aygen M, Levy E, Ventura E, Shadhdi J. The effect of ketamine on pulmonary artery pressure. J Anesth. 1974;29:141–146
  146. Morray JP, Lynn AM, Stamm SJ, Herndon PS, Kawabori I, Stevenson JG. Hemodynamic effects of ketamine in children with congenital heart disease. Anesth Analg. 1984;63:895–899
  147. Hickey PR, Hansen DD, Cramolini GM, Vincent RN, Lang P. Pulmonary and systemic hemodynamic responses to ketamine in infants with normal and elevated pulmonary vascular resistance. Anesthesiology. 1985;62:287–293
  148. Wigle ED, Rakowski H, Kimball BP, Williams WG. Hypertrophic cardiomyopathy (Clinical spectrum and treatment). [review] Circulation. 1995;92:1680–1692
  149. Spirito P, Seidman C, McKenna WJ, Maron BJ. The management of hypertrophic cardiomyopathy. [review] N Engl J Med. 1997;336:775–785
  150. Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006;113:1807–1816
  151. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy (A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines). J Am Coll Cardiol. 2003;42:1687–1713
  152. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. [review] JAMA. 2002;287:1308–1320
  153. Starnes VA, Bernstein D, Oyer PE, Gamberg PL, Miller JL, Baum D, et al. Heart transplantation in children. J Heart Transplant. 1989;8:20–26
  154. Warner MA, Lunn RJ, O'Leary PW, Schroeder DR. Outcomes of noncardiac surgical procedures in children and adults with congenital heart disease. Mayo Clin Proc. 1998;73:728–734
  155. Carmosino MJ, Friesen RH, Doran A, Ivy DD. Perioperative complications in children with pulmonary hypertension undergoing non cardiac surgery or cardiac catheterization. Anesth Analg. 2007;104:521–527
  156. Wolfe RR, Loehr JP, Schaffer MS, Wiggins JW. Hemodynamic effects of ketamine, hypoxia and hyperoxia in children with surgically treated congenital heart disease residing 1200 meters above sea level. Am J Cardiol. 1991;67:84–87
  157. Williams GD, Jones TK, Hanson KA, Morray JP. The hemodynamic effects of propofol in children with congenital heart disease. Anesth Analg. 1999;89:1411–1416
  158. Hickey PR, Hansen DD, Wessel DL, Lang P, Jonas RA. Pulmonary and systemic hemodynamic responses to fentanyl in infants. Anesth Analg. 1985;64:483–486
  159. Chanavaz C, Tirel O, Wodey E, Bansard JY, Senhadji L, Robert JC, et al. Haemodynamic effects of remifentanil in children with and without intravenous atropine: an echocardiographic study. Br J Anaesth. 2005;94:74–79
  160. Blaise G, Langleben D, Hubert B. Pulmonary arterial hypertension: pathophysiology and anesthetic approach. [review] Anesthesiology. 2003;99:1415–1432
  161. van Son JA, Edwards WD, Danielson GK. Pathology of coronary arteries, myocardium, and great arteries in supravalvular aortic stenosis. J Thorac Cardiovasc Surg. 1994;108:21–28
  162. Terhune PE, Buchino JJ, Rees AH. Myocardial infarction associated with supravalvular aortic stenosis. J Pediatr. 1985;106:251–254
  163. Conway EE, Noonan J, Marion RW, Steeg CN. Myocardial infarction leading to sudden death in the Williams syndrome: report of three cases. J Pediatr. 1990;117:593–595
  164. Black JA, Carter RE. Association between aortic stenosis and facies of severe infantile hypercalcemia. Lancet. 1963;2:745–748
  165. Bird LM, Billman GF, Lacro RV, Spicer RL, Jariwala LK, Hoyme HE, et al. Sudden death in Williams syndrome: report of ten cases. J Pediatr. 1996;129:926–931
  166. Lacro RV, Perry SB, Keane JF, Castenata AR, Lock JE. Combined transcatheter and surgical therapy for severe bilateral outflow tract obstruction in Williams syndrome and familial supravalvular aortic stenosis. Circulation. 1994;90:1–587
  167. Pansegrau DG, Martin MM, Kioshos JM, Dumin RE, Kroetz FW. Supravalvular aortic stenosis in adults. Am J Cardiol. 1973;31:635–641
  168. Morrow AG, Waldhausen JA, Peters RL, Blood-well RD, Braunwald E. Supravalvular aortic stenosis: clinical, hemodynamic and pathologic observations. Circulation. 1959;20:1003–1010
  169. Martin MM, Lemmer JH, Shaffer E, Dick M, Bove EL. Obstruction to left coronary artery blood flow secondary to obliteration of the coronary ostium in supravalvular aortic stenosis. Ann Thorac Surg. 1988;45:16–20
  170. Kahler RL, Braunwald E, Planth WH, Morrow AG. Familial congenital heart disease. Am J Med. 1966;40:384–399
  171. Blieden LC, Lucas RV, Carter JB, Miller K, Edwards JE. A developmental complex including supravalvular stenosis of the aorta and pulmonary trunk. Circulation. 1974;49:585–590
  172. Sehmidt RE, Gilbert EF, Amend TC, Chamberlain CR, Lucas RV. Generalized arterial fibromuscular dysplasia and myocardial infarction in familial supravalvular aortic stenosis syndrome. J Pediatr. 1969;74:576–584
  173. Cheu S, Fiese MJ, Hatayama E. Supra-aortic stenosis: congenital, supra-aortic valvular, stenosing membrane on the aortic cusps. Am J Clin Pathol. 1957;28:293–300
  174. Horowitz PE, Akhtar S, Wulff JA, Al Fadley F, Al Halees Z. Coronary artery disease and anesthesia-related death in children with Williams syndrome. J Cardiothorac Vasc Anesth. 2002;16:739–741
  175. Denie JJ, Verheugt AP. Supravalvular aortic stenosis. Circulation. 1958;18:902–908
  176. Longnecker DE, Tinker JH, Morgan GE. Principles and Practice of Anesthesiology. 2nd ed.. St. Louis, MO: Mosby; 1998;
  177. Harmel M, Lamont A. Anesthesia in the surgical treatment of pulmonic stenosis. Anesthesiology. 1946;7:477–498
  178. Van Norman G, Jackson SG, Waisel D. Informed consent: ethical implications in clinical practice. Curr Opin Anaesthesiol. 2004;17:177–181
  179. Morray JP, Geiduschek JM, Ramamoorthy C, Haberkern CM, Hackel A, Caplan RA, et al. Anesthesia-related cardiac arrest in children: initial findings of the Pediatric Perioperative Cardiac Arrest (POCA) Registry. Aneshesiology. 2000;93:6–14
  180. Lewis I, Burke C, Voepel-Lewis T, Tait AR. Children who refuse anesthesia or sedation: a survey of anesthesiologists. Paediatr Anaesth. 2007;17:1134–1142
  181. Domino KB, Bowdle TA, Posner KL, Spitellie PH, Lee LA, Cheney FW. Injuries and liability related to central vascular catheters: a closed claims analysis. Anesthesiology. 2004;100:1411–1418
  182. Sundar S, DiNardo JA. Transesophageal echocardiography in pediatric surgery. Int Anesthesiol Clin. 2008;46:137–155
  183. Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and The Council on Clinical Cardiology, Council on Cardiovascular Surgery and anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. J Am Dent Assoc. 2007;138:739–745747-60
  184. Mangano DT, Tudor IC, Dietzel C. Multicenter Study of Perioperative Ischemia Research Group; Ischemia Research and Education Foundation (The risk associated with aprotinin in cardiac surgery). N Engl J Med. 2006;354:353–365
  185. Eaton M. Antifibrinolytic therapy in surgery for congenital heart disease. Anesth Analg. 2008;106:1087–1100
  186. Aronson LA, Spaeth JP. Frontiers in pediatric anesthesia: cardiac anesthesia. Int Anesthesiol Clin. 2006;44:33–49
  187. Andropoulos DB, Stayer SA, Diaz LK, Ramamoorthy C. Neurological monitoring for congenital heart surgery. Anesth Analg. 2004;99:1365–1375
  188. Hoffman TM, Wernovsky G, Atz AM, Kulik TJ, Nelson DP, Chang AC, et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation. 2003;107:996–1002
  189. Park KW. Protamine and protamine reactions. Int Anesthesiol Clin. 2004;42:135–145
  190. Seifert HA, Jobes DR, Ten Have T, Kimmel SE, Montenegro LM, Steven JM, et al. Adverse events after protamine administration following cardiopulmonary bypass in infants and children. Anesth Analg. 2003;97:383–389
  191. Hosokawa K, Shime N, Kato Y, Taniguchi A, Maeda Y, Miyazaki T, et al. Dexmedetomidine sedation in children after cardiac surgery (Pediatric Critical Care Medicine). Pediatr Crit Care Med. 2010;11:39–43
  192. Kirshbom PM, Myung RJ, Simsic JM, Kramer ZB, Leong T, Kogon BE, et al. One thousand repeat sternotomies for congenital cardiac surgery: risk factors for reentry injury. Ann Thorac Surg. 2009;88:158–161
  193. Monro LJ, Alexiou C, Salmon AP, Keeton BR. Reoperations and survival after primary repair of congenital heart defects in children. T Thorac Cardiovasc Surg. 2003;126:511–520
  194. Shumacker HB. The birth of an idea and the development of cardiopulmonary bypass. In:  Gravlee GP,  Davis RF,  Stammers AH,  Ungerleider RM editor. Cardiopulmonary Bypass—Principles and Practice. 3rd ed.. Philadelphia, PA: Wolters KluwerHealth–Lippincott Williams & Wilkins; 2008;
  195. Lillehei CW, Varco RL, Cohen M, Warden HE, Patton C, Moller J. The first open-heart repairs of ventricular septal defect, atrioventicular communis, and tetralogy of fallot using extracorporeal circulation by cross-circulation: a 30-year follow-up. Ann Thorac Surg. 1986;41:4–21
  196. Giacomuzzi C, Mejak B, Shen I. Pediatric cardiopulmonary bypass (Overview: state of the art and future). In:  Gravlee GP,  Davis RF,  Stammers AH, et al. editor. Cardiopulmonary Bypass-Principles and Practice. 3rd ed.. Philadelphia, PA: Wolters KluwerHealth–Lippincott Williams & Wilkins; 2008;p. 685–734
  197. Jones TJ, Elliot MJ. Paediatric CPD: bypass in a high risk group. Perfusion. 2006;21:229–233
  198. Groom RC, Froebe S, Martin J, Manfra MJ, Cormack JE, Morse C, et al. Update on pediatric perfusion practice in North America: 2005 survey. J Extra Corpor Technol. 2005;37:343–350
  199. Ungerleider R. Practice patterns in neonatal cardiopulmonary bypass. Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2004;7:172–179
  200. McQuillen PS, Barkovich AJ, Hamrick SE, Perez M, Ward P, Glidden DV, et al. Temporal and anatomic risk profile of brain injury with neonatal repair of congenital heart defects. Stroke. 2007;38(suppl):736–741
  201. McQuillen PS, Hamrick SE, Perez MJ, Barkovich AJ, Glidden DV, Karl TR, et al. Balloon atrial septostomy is associated with preoperative stroke in neonates with transposition of the great arteries. Circulation. 2006;113:280–285
  202. Galli KK, Zimmerman RA, Jarvik GP, Wernovsky G, Kuypers MK, Clancy RR, et al. Periventricular leukomalacia is common after neonatal cardiac surgery. J Thorac Cardiovasc Surg. 2004;127:692–704
  203. Hoffman JIE, Rudolph AM, Heymann MA. Pulmonary vascular disease with congenital heart lesions: pathologic features and causes. Circulation. 1981;64:873–877
  204. McMullan DM, Bekker JM, Parry AJ, Johengen MJ, Kon A, Heidersbach RS, et al. Alterations in endogenous nitric oxide production after cardiopulmonary bypass in lambs with normal and increased pulmonary blood flow. Circulation. 2000;102(19 suppl 3):III172–III178
  205. Mossad E, Motta P, Sehmbey K, Toscana D. The hemodynamic effects of phenoxybenzamine in neonates, infants, and children. J Clin Anesth. 2008;20:94–98
  206. Taylor KM. Cardiopulmonary Bypass. London, United Kingdom: Chapman & Hall; 1986;
  207. Noris M, Morigi M, Donadelli R, Aiello S, Foppolo M, Todeschini M, et al. Nitric oxide synthesis by cultured endothelial cells is modulated by flow conditions. Circ Res. 1995;76:536–543
  208. Alkan T, Akçevin A, Undar A, Türkoğlu H, Paker T, Aytaç A. Effects of pulsatile and nonpulsatile perfusion on vital organ recovery in pediatric heart surgery: a pilot clinical study. ASAIO J. 2006;52:530–535
  209. Alkan T, Akçevin A, Undar A, Türkoğlu H, Paker T, Aytaç A. Benefits of pulsatile perfusion on vital organ recovery during and after pediatric open heart surgery. ASAIO J. 2007;53:651–654
  210. Greeley WJ, Kern FH, Ungerleider RM, Boyd JL, Quill T, Smith LR, et al. The effect of hypothermic cardiopulmonary bypass and total circulatory arrest on cerebral metabolism in neonates, infants, and children. J Thorac Cardiovasc Surg. 1991;101:783–794
  211. Rebeyka IM, Hana SA, Borges MR, Lee KF, Yeh T, Tuchy GE, et al. Rapid cooling contracture of the myocardium (The adverse effect of prearrest cardiac hypothermia). J Thorac Cardiovasc Surg. 1990;100:240–249
  212. Kurihara S, Sakai T. Effects of rapid cooling on mechanical and electrical responses in ventricular muscle of guinea-pig. J Physiol. 1985;361:361–378
  213. Bridge JH. Relationships between the sarcoplasmic reticulum and sarcolemmal calcium transport revealed by rapidly cooling rabbit ventricular muscle. J Gen Physiol. 1986;88:437–473
  214. Bers DM, Bridge JH, Spitzer KW. Intracellular Ca 2+ transients during rapid cooling contractures in guinea-pig ventricular myocytes. J Physiol. 1989;417:537–553
  215. Williams WG, Rebeyka IM, Tibshirani RJ, Coles JG, Lightfoot NE, Mehra A, et al. Warm induction blood cardioplegia in the infant (A technique to avoid rapid cooling myocardial contracture). J Thorac Cardiovasc Surg. 1990;100:896–901
  216. Torchiana DF, Love TR, Hendren WG, Geffin GA, Titus JS, Redonnett BE, et al. Calcium induced ventricular contraction during cardioplegic arrest. J Thorac Cardiovasc Surg. 1987;94:606–613
  217. Cannon MB, Vine AJ, Kantor HL, Lahorra JA, Nickell SA, Hahn C, et al. Warm and cold blood cardioplegia (Comparison of myocardial function and metabolism using 31p magnetic resonance spectroscopy). Circulation. 1994;90(5 Pt. 2):II329–II338
  218. Lahorra JA, Torchiana DF, Tolis G, Bashour CA, Hahn C, Titus JS, et al. Rapid cooling contracture with cold cardioplegia. Ann Thorac Surg. 1997;63:1353–1360
  219. Aoki M, Nomure F, Kawate H, Mayer JE. Effect of calcium and preischemic hypothermia on recovery of myocardial function after cardioplegic ischemia in neonatal lambs. J Thorac Cardiovasc Surg. 1993;105:207–212discussion 212-3
  220. Reddy VM, Hanley FL. Techniques to avoid circulatory arrest in neonates undergoing repair of complex heart defects. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2001;4:277–280
  221. Langley SM, Chai PJ, Miller SE, Mault JR, Jaggers JJ, Tsui SS, et al. Intermittent perfusion protects the brain during deep hypothermic circulatory arrest. Ann Thorac Surg. 1999;68:4–13
  222. Durandy YD, Younes M, Mahut B. Pediatric warm open heart surgery and prolonged cross-clamp time. Ann Thorac Surg. 2008;86:1941–1947
  223. Boldt J, Knothe C, Welters I, Dapper F, Hempelmann G. Normothermic versus hypothermic cardiopulmonary bypass: do changes in coagulation differ?. Ann Thorac Surg. 1996;62:130–135
  224. Mazer CD, Hornstein A, Freedman J. Platelet activation in warm and cold heart surgery. Ann Thorac Surg. 1996;59:1481–1486
  225. Warm Heart Investigators. Randomised trial of normothermic versus hypothermic coronary bypass surgery. Lancet. 1994;343:559–563
  226. Birdi I, Regragui I, Izzat MB, Bryan AJ, Angelini GD. Influence of normothermic systemic perfusion during coronary artery bypass operations: a randomized prospective study. J Thorac Cardiovasc Surg. 1997;114:475–481
  227. Kirshbom PM, Skaryak LR, DiBernardo LR, Kern FH, Greeley WJ, Gaynor JW. Benefits of pulsatile perfusion on vital organ recovery during and after pediatric open heart surgery. J Thorac Cardiovasc Surg. 1996;111:145–155discussion 156-7
  228. Allen BS. Current concepts in pediatric myocardial protection. In:  Salerno TA,  Ricci M editor. Myocardial Protection. Elmsford, NY: Futura, Blackwell; 2004;p. 207–229
  229. Hammon JW. Myocardial protection in the immature heart. Ann Thorac Surg. 1995;60:839–842
  230. Doenst T, Schlensak C, Beyersdorf F. Cardioplegia in pediatric cardiac surgery: do you believe in magic?. [review] Ann Thorac Surg. 2003;75:1668–1677
  231. Chai PJ. Myocardial protection and preservation for neonates and infants. In:  Gravlee GP,  Davis RF,  Stammers AH,  Ungerleider RM editor. Cardiopulmonary Bypass—Principles and Practice. Philadelphia, PA: Wolters KluwerHealth-Lippincott Williams & Wilkins; 2008;p. 700–709
  232. Bittira B, Shum-Tim D, Tchervenkov CI. New concepts in myocardial protection in pediatric cardiac surgery. In:  Salerno TA,  Ricci M editor. Myocardial Protection. Elmsford, NY: Futura, Blackwell; 2004;p. 264–274
  233. Lopaschuk GD, Collins-Nakai RL, Itoi T. Developmental changes in energy substrate use by the heart. Cardiovasc Res. 1992;26:1172–1180
  234. Kodde IF, van der Stok J, Smolenski RT, de Jong JW. Metabolic and genetic regulation of cardiac energy substrate preference. Comp Biochem Physiol A Mol Integr Physiol. 2007;146:26–39
  235. Jung DH, Lee CJ, Suh CK, You HJ, Kim DH. Molecular properties of excitation-contraction coupling proteins in infant and adult human heart tissues. Mol Cells. 2005;20:51–56
  236. Grice WN, Konishi T, Apstein CS. Resistance of neonatal myocardium to injury during normothermic and hypothermic ischemic arrest and reperfusion. Circulation. 1987;76(suppl 5):150
  237. Bove EL, Gallagher KP, Drake DH. The effect of hypothermic ischemia on recovery of left ventricular function and preload reserve in the neonatal heart. J Thorac Cardiovasc Surg. 1988;95:814–818
  238. Bull C, Cooper J, Stark J. Cardioplegic protection of the child's heart. J Thorac Cardiovasc Surg. 1988;95:223–229
  239. Lupinetti FM, Wareing TH, Huddleston CB, Collins JC, Boucek RJ, Bender HW, et al. Pathophysiology of chronic cyanosis in a canine model: functional and metabolic response to global ischemia. J Thorac Cardiovasc Surg. 1985;90:291–296
  240. del Nido PJ, Mickle DA, Wilson GJ, Benson LN, Weisel RD, Coles JG, et al. Inadequate myocardial protection with cold cardioplegic arrest during repair of tetralogy of Fallot. J Thorac Cardiovasc Surg. 1988;95:223–229
  241. Graham TP, Erath HG, Buckspan GS, Fisher RD. Myocardial anaerobic metabolism during isoprenaline infusion in a cyanotic animal model: possible cause of myocardial dysfunction in cyanotic congenital heart disease. Cardiovasc Res. 1979;13:401–406
  242. Buckberg GD, Allen BS. Myocardial protection management during adult cardiac operations. In:  Baue AE,  Geha AS,  Hammond GL, et al. editor. Glenn's Thoracic and Cardiovascular Surgery. East Norwalk, CT: Appleton and Lange; 1995;p. 1653–1687
  243. Bolling KS, Kronon M, Allen BS, Ramon S, Wang T, Hartz RS, et al. Myocardial protection in normal and hypoxically stressed neonatal hearts: the superiority of blood versus crystalloid cardioplegia. J Thorac Cardiovasc Surg. 1997;113:994–1005
  244. Modi P, Suleiman MS, Reeves B, Pawade A, Parry AJ, Angelini GD, et al. Myocardial metabolic changes during pediatric cardiac surgery: a randomized study of 3 cardioplegic techniques. J Thorac Cardiovasc Surg. 2004;128:67–75
  245. Lareau S, Boyle AJ, Stewart LC, Deslauriers R, Hendry P, Keon WJ, et al. The role of magnesium in myocardial preservation. Magnes Res. 1995;8:85–97
  246. Kronon MI, Allen BS, Hernan J, Halldorsson AO, Rahman S, Buckberg GD, et al. Superiority of magnesium cardioplegia in neonatal myocardial protection. Ann Thorac Surg. 1999;68:2285–2291discussion 2291-2
  247. Kronon M, Allen BS, Bolling KS, Rahman S, Wang T, Maniar HS, et al. The role of cardioplegic induction temperature and amino acid enrichment in neonatal myocardial protection. Ann Thorac Surg. 2003;3:756–764
  248. Allen BS. Pediatric myocardial protection: a cardioplegic strategy is the “solution”. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2004;7:141–154
  249. Follette D, Fey K, Buckberg GD, Helly JJ, Steed DL, Foglia RP, et al. Reducing post-ischemic damage by temporary modifications of reperfusate calcium, potassium, pH, and osmolarity. J Thorac Cardiovasc Surg. 1981;82:221–238
  250. Allen BS, Okamoto F, Buckberg GD, Bugyi H, Young H, Leaf J, et al. Studies of controlled perfusion after ischemia: immediate functional recovery after 6 hours of regional ischemia by careful control of conditions of reperfusion and composition of reperfusate. J Thorac Cardiovasc Surg. 1986;92:621–663
  251. Teoh KH, Christiakis GT, Weisel RD, Fremes SE, Mickle DA, Romaschin AD, et al. Accelerated myocardial metabolic recovery with terminal warm blood cardioplegia. J Thorac Cardiovasc Surg. 1986;91:888–895
  252. Kirklin J, Barrat-Boyes B. Myocardial management during cardiac surgery with cardiopulmonary bypass. In:  Kirklin J,  Barrat-Boyes B editor. Cardiac Surgery. New-York, NY: Churchill–Livingstone; 1993;
  253. Kronon M, Allen BS, Rahman S, Wang T, Tayyab NA, Bolling KS, et al. Reducing post ischemic reperfusion damage in neonates using a terminal warm substrate enriched blood cardioplegic reperfusate. Ann Thorac Surg. 2000;70:765–770
  254. Toyoda Y, Yamaguchi M, Yoshimura N, Oka S, Okita Y. Cardioprotective effects and the mechanisms of terminal warm blood cardioplegia in pediatric cardiac surgery. J Thorac Cardiovasc Surg. 2003;125:1241–1251
  255. Taggart DP, Hadjinikolas L, Hooper J, Albert J, Kemp M, Hue D, et al. Effects of age and ischemic times on biochemical evidence of myocardial injury after pediatric cardiac operations. J Thorac Cardiovasc Surg. 1997;113:728–735
  256. Buckberg GD, Allen BS, Beyersdorf F. Blood cardioplegic strategies during adult cardiac operations. In:  Piper HM,  Preusse CJ editor. Ischemia-Reperfusion in Cardiac Surgery. Dordrecht, Netherlands: Kluwer Academic; 1993;p. 181–227
  257. Buckberg GD, Beyersdorf F, Allen BS. Integrated myocardial management: background and initial application. J Cardiovasc Surg. 1995;10:68–89
  258. Rosenkranz ER, Feng J, Li HL. Myocardial preconditioning in the experimental model: a new strategy to improve myocardial protection. In:  Salerno TA,  Ricci M editor. Myocardial Protection. Elmsford, NY: Futura, Blackwell; 2004;p. 230–263
  259. Cheung MM, Kharbanda RK, Konstantinov IE, Shimizu M, Frndova H, Li J, et al. Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery. J Am Coll Cardiol. 2006;47:2277–2282
  260. Elliott MJ. Ultrafiltration and modified ultrafiltration in pediatric open-heart operations. [review] Ann Thorac Surg. 1993;56:1518–1522
  261. Ungerleider RM. Effects of cardiopulmonary bypass and use of modified ultrafiltration. Ann Thorac Surg. 1998;65(suppl):S35–S39discussion S39, S74-6
  262. Millar AB, Armstrong L, van der Linden J. Cytokine production and hemofiltration in children undergoing cardiopulmonary bypass. Ann Thorac Surg. 1993;56:1499–1502
  263. Zahler S, Massoudy P, Hartl H, Hähnel C, Meisner H, Becker BF. Acute cardiac inflammatory responses to postischemic reperfusion during cardiopulmonary bypass. Cardiovasc Res. 1999;41:722–730
  264. Rinder CS, Bonan JL, Rinder HM, Mathew J, Hines R, Smith BR. Cardiopulmonary bypass induces leukocyte-platelet adhesion. Blood. 1992;79:1201–1205
  265. Moat NE, Shore DF, Evans TW. Organ dysfunction and cardiopulmonary bypass: the role of complement and complement regulatory proteins. [review] Eur J Cardio Thorac Surg. 1993;7:563–573
  266. Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1983;86:845–857
  267. Oudemans-van Straaten HM, Jansen PG, Hoek FJ, van Deventer SJ, Sturk A, Stoutenbeek CP, et al. Intestinal permeability, circulating endotoxin, and postoperative systemic responses in cardiac surgery patients. J Cardiothorac Vasc Anesth. 1996;10:187–194
  268. Madhok AB, Ojamaa K, Haridas V, Parnell VA, Pahwa S, Chowdhury D. Cytokine response in children undergoing surgery for congenital heart disease. Pediatr Cardiol. 2006;27:408–413
  269. Cremer J, Martin M, Redl H, Bahrami S, Abraham C, Graeter T, et al. Systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg. 1996;61:1714–1720
  270. Seghaye MC, Duchateau J, Grabitz RG, Faymonville ML, Messmer BJ, Buro-Rathsmann K, et al. Complement activation during cardiopulmonary bypass in infants and children: relation to postoperative multiple system organ failure. J Thorac Cardiovasc Surg. 1993;106:978–987
  271. Holmes JH, Connolly NC, Paull DL, Hill ME, Guyton SW, Ziegler SF, et al. Magnitude of the inflammatory response to cardiopulmonary bypass and its relation to adverse clinical outcomes. Inflamm Res. 2002;51:579–586
  272. Pavelková M, Kubala L, Cíz M, Pavlík P, Wagner R, Slavík J, et al. Blood phagocyte activation during open heart surgery with cardiopulmonary bypass. Physiol Res. 2006;55:165–173
  273. Paparella D, Yau TM, Youngg E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment: an update. Eur J Cardio Thorac Surg. 2002;21:232–244
  274. Naik SK, Knight A, Elliott M. A prospective randomized study of a modified technique of ultrafiltration during pediatric open-heart surgery. Circulation. 1991;84(suppl):III422–III431
  275. Schroeder VA, Pearl JM, Schwartz SM, Shanley TP, Manning PB, Nelson DP. Combined steroid treatment for congenital heart surgery improves oxygen delivery and reduces postbypass mediator expression. Circulation. 2003;107:2823–2828
  276. Tassani P, Richter JA, Barankay A, Braun SL, Haehnel C, Spaeth P, et al. Does high-dose methylprednisolone in aprotinin-treated patients attenuate the systemic inflammatory response during coronary artery bypass grafting procedures?. J Cardiothorac Vasc Anesth. 1999;13:165–172
  277. Hoffman TM, Wernovsky G, Atz AM, Bailey JM, Akbary A, Kocsis JF, et al. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study (Prophylactic intravenous use of milrinone after cardiac operation in pediatrics). Am Heart J. 2002;143:15–21
  278. Guibourdenche M, Høiby EA, Riou JY, Varaine F, Joguet C, Caugant DA. Epidemics of serogroup A Neisseria meningitidis of subgroup III in Africa, 1989-94. Epidemiol Infect. 1996;116:115–120
  279. Mayumi H, Zhang QW, Nakashima A, Masuda M, Kohno H, Kawachi Y, et al. Synergistic immunosuppression caused by high-dose methylprednisolone and cardiopulmonary bypass. Ann Thorac Surg. 1997;63:129–137
  280. Checchia PA, Backer CL, Bronicki RA, Baden HP, Crawford SE, Green TP, et al. Dexamethasone reduces postoperative troponin levels in children undergoing cardiopulmonary bypass. Crit Care Med. 2003;31:1742–1745
  281. Giomarelli P, Scolletta S, Borrelli E, Biagioli B. Myocardial and lung injury after cardiopulmonary bypass: role of interleukin (IL)-10. Ann Thorac Surg. 2003;77:117–123
  282. Pearl JM, Schwartz SM, Nelson DP, Wagner CJ, Lyons JM, Bauer SM, et al. Preoperative glucocorticoids decrease pulmonary hypertension in piglets after cardiopulmonary bypass and circulatory arrest. Ann Thorac Surg. 2004;77:994–1000
  283. Kilger E, Weis F, Briegel J, Frey L, Goetz AE, Reuter D, et al. Stress doses of hydrocortisone reduce severe systemic inflammatory response syndrome and improve early outcome in a risk group of patients after cardiac surgery. Crit Care Med. 2003;31:1068–1074
  284. Schroeder VA, Pearl JM, Schwartz SM, Shanley TP, Manning PB, Nelson DP. Combined steroid treatment for congenital heart surgery improves oxygen delivery and reduces post bypass mediator expression. Circulation. 2003;107:2823–2828
  285. Chaney MA, Nikolov MP, Blakeman P, Bakhos M, Slogoff S. Hemodynamic effects of methylprednisolone in patients undergoing cardiac operation and early extubation. Ann Thorac Surg. 1999;67:1006–1011
  286. Chaney MA, Nikolov MP, Blakeman B, Bakhos M, Slogoff S. Pulmonary effects of methylprednisolone in patients undergoing coronary artery bypass grafting and early tracheal extubation. Anesth Analg. 1998;87:27–33
  287. Checchia PA, Bronicki RA, Costello JM, Nelson DP. Steroid use before pediatric cardiac operations using cardiopulmonary bypass: an international survey of 36 centers. Pediatr Crit Care Med. 2005;6:441–444
  288. Wan S, DeSmet JM, Barvais L, Goldstein M, Vincent JL, LeClerc JL. Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1996;112:806–811
  289. Shum-Tim D, Tchervenkov CI, Laliberté E, Jamal AM, Nimeh T, Luo CY, et al. Timing of steroid treatment is important for cerebral protection during cardiopulmonary bypass and circulatory arrest: minimal protection of pump prime methylprednisolone. Eur J Cardio Thorac Surg. 2003;24:125–132
  290. Lodge AJ, Chai PJ, Daggett CW, Ungerleider RM, Jaggers J. Methylprednisolone reduces the inflammatory response to cardiopulmonary bypass in neonatal piglets: timing of dose is important. J Thorac Cardiovasc Surg. 1999;117:515–522

PII: S0011-3840(09)00168-3

doi: 10.1067/j.cpsurg.2009.11.006

Current Problems in Surgery
Volume 47, Issue 3 , Pages 185-250 , March 2010

Article Tools

* Image Usage & Resolution